...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease
【24h】

Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease

机译:在阿尔茨海默病领域的多目标药物发现和有前途应用的进步

获取原文
获取原文并翻译 | 示例

摘要

Complex diseases (e.g., Alzheimer's disease) or infectious diseases are usually caused by complicated and varied factors, including environmental and genetic factors. Multi-target (polypharmacology) drugs have been suggested and have emerged as powerful and promising alternative paradigms in modern medicinal chemistry for the development of versatile chemotherapeutic agents to solve these medical challenges. The multifunctional agents capable of modulating multiple biological targets simultaneously display great advantages of higher efficacy, improved safety profile, and simpler administration compared to single-targeted agents. Therefore, multifunctional agents would certainly open novel avenues to rationally design the next generation of more effective but less toxic therapeutic agents. Herein, the authors review the recent progress made in the discovery and design processes of selective multi targeted agents, especially the successful application of multi-target drugs for the treatment of Alzheimer's disease. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:复杂疾病(例如,阿尔茨海默病)或传染病通常是由复杂和多种因素引起的,包括环境和遗传因素。已经提出了多目标(多药动学)药物,并在现代药用化学方面发出了强大而有前途的替代范式,以开发多功能化学治疗剂来解决这些医疗挑战。能够调节多种生物学靶标的多官能剂同时显示出效率更高,改进的安全性曲线和更简单的给药的优点,与单靶剂相比。因此,多功能药剂肯定会开放新颖的途径,以合理设计下一代更有效但较低的毒性治疗剂。在此,作者审查了最近在选择性多目标药物的发现和设计过程中进行的最新进展,尤其是成功应用多目标药物治疗阿尔茨海默病的疾病。 (c)2019年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号